The Lonza small biotech series highlights the critical components that smaller innovators need to enjoy successful relationships with CDMOs. Here, the journeys of four diverse biotechs show the value of Flexibility.

You may also be interested in:
Mammalian
Latest briefing from the Knowledge Center
Two men working in the lab micro pipetting.
R&D Blog post
In-use stability and compatibility of Biologics – How to safely administer an effective medicinal...
CDMO Notes Blog post
Accelerated Tox Offerings: A Recipe for Streamlining IND Applications
Webinar (on-demand)
Lonza Biologics Drug Product OPCU Capacity Update
Explore Lonza Biologics' end-to-end Drug Product capabilities along the full life cycle, seamlessly...
CDMO Notes Blog post
A Faster Path to the Clinic: Accelerating Biologics Development with Integrated Solutions
How Lonza’s team are helping to revolutionise the path to Biologics INDs, with an accelerated...
Podcast
A View On mRNA Encapsulation (S04 E03)
In this episode, we are joined by three experts—Christoph Hein (Fraunhofer IPK), Bern-hard Bobusch...
Protein image
White paper
From Discovery to Patients: an Integrated Service for ADC Development by Lonza and Synaffix
This white paper provides an in-depth look at the development and challenges of antibody-drug...
Webinar (on-demand)
Charting a Successful CMC Journey for Your ADC Drug Product
Bioconjugates and Antibody drug conjugates (ADCs) are revolutionizing cancer therapy with their...
ADC vial with gradient background - close crop
Interview
Expert Q&A: Accelerate Your ADC Journey
Filling the Need for Integrated Bioconjugate Solutions Antibody drug conjugates (ADCs) are...
KC Video thumbnail
Video
mRNA and LNP Encapsulation Capabilities at our Geleen/NL Center of Excellence
Discover how our team, with its impressive mRNA/LNP track record, can help you progress your...
Mammalian Biologics Drug Substance Manufacture MC1
Article
How Emerging Biotechs can Benefit by Partnering with a CDMO for Early Stage Development
The partnership between CDMOs and emerging biotech companies in early-stage development can be...
Shaped Around You Bispecific Antibody Molecule and hand
Podcast
A View On Antibody-Based Therapies (S04 E02)
In this episode, we are joined by Ronnie Wei, Head of Biologics Discovery and Devel-opment at ModeX...
Webinar (on-demand)
Early Preclinical Development of mRNA/LNP Projects, Transitioning Successfully to cGMP...
View our on-demand webinar exploring the development steps that lead to an mRNA construct optimized...